SOPHIA ANTIPOLIS, France, November 20 (HSMN NewsFeed) -- With the recent FDA approval of LMS-Lung/Track and LMS-Liver, two applications dedicated to the evaluation and follow-up of cancerous or other potentially malignant lesions identified in chest and liver CT images, MEDIAN Technologies succeeds in setting the trend in diagnostic oncology imaging. The company will showcase its complete portfolio of Lesion Management Solutions at the 93rd annual meeting of the Radiological Society of North America (RSNA) in Chicago, hall B, booth #8548.
Full text >>
Tuesday, November 20, 2007
MEDIAN Technologies Lesion Management Solutions Set the Trend in Diagnostic Oncology Imaging at RSNA 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment